Zhuorong Li
- Pharmacology top 0.5%
- Pharmacology top 0.5%
- Organic Chemistry top 2%
- Synthesis and biological activity 15
- Synthesis and Biological Evaluation 10
- Toxicology top 2%
- Molecular Biology top 5%
- Bone Metabolism and Diseases 11
- Cancer therapeutics and mechanisms 11
-
- Hepatitis C virus research 15
-
- Antibiotic Resistance in Bacteria 11
-
- HIV/AIDS drug development and treatment 10
-
- Viral Infections and Immunology Research 9
- Cited by
- PharmacologyOrganic Chemistry
- Journals
- Journal of Biological Chemistry (1 paper)Nature Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zhuorong Li
166 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Pharmacology 1.3k
- Pharmacology 554
- Organic Chemistry 862
- Toxicology 99
- Molecular Biology 1.9k
Countries citing papers authored by Zhuorong Li
This map shows the geographic impact of Zhuorong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuorong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuorong Li more than expected).
Fields of papers citing papers by Zhuorong Li
This network shows the impact of papers produced by Zhuorong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuorong Li. The network helps show where Zhuorong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhuorong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 21 | |
| 9 | 2021 | 34 | |
| 10 | 2021 | 19 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 24 | |
| 13 | 2020 | 4 | |
| 14 | 2017 | 7 | |
| 15 | [Research progress of HCV NS5A complex inhibitors]. | 2016 | 1 |
| 16 | 2016 | 44 | |
| 17 | 2015 | 12 | |
| 18 | 2015 | 58 | |
| 19 | 2009 | 3 | |
| 20 | Researches of constituents and bioactivity of Salvia spp. | 2007 | 2 |
About Zhuorong Li
Zhuorong Li is a scholar working on Molecular Medicine, Hepatology and Virology, having authored 171 papers that have together received 4.4k indexed citations. Recurring topics across this work include Synthesis and biological activity (15 papers), Hepatitis C virus research (15 papers), Antibiotic Resistance in Bacteria (11 papers), Bone Metabolism and Diseases (11 papers), Cancer therapeutics and mechanisms (11 papers), Synthesis and Biological Evaluation (10 papers), HIV/AIDS drug development and treatment (10 papers) and Viral Infections and Immunology Research (9 papers). The work is most often cited by research in Pharmacology (1.3k citations), Pharmacology (554 citations) and Organic Chemistry (862 citations). Zhuorong Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jian‐Dong Jiang, Shuyi Si, Weijia Kong, Jing Wei, Cong Li, Parveen Abidi, Yanling Wang, Satoru Inaba, Shukui Wang and Meihong Lin. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.